CYP3A4 and benign prostatic hyperplasia: Our previous nested case–control association studies showed that a constitutive CYP3A4 and VDRTaqI SNPs are associated with a group of men with BPH who are at an increased risk of PRCa (Tayeb et al, 2002, submitted).